SN

Synektik SAWSE Synektik Stock Report

Last reporting period 30 Jun, 2024

Updated 22 Oct, 2024

Last price

Market cap $B

0.402

Micro

Exchange

XWAR - Warsaw Stock Exchange

SNT.WA Stock Analysis

SN

Attractive

Based on Eyestock quantitative analysis, SNT.WA`s fundamental data and valuation indicate an investment grade of Attractive at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

112/100

High score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

60.2 %

Undervalued

Market cap $B

0.402

Dividend yield

2.30 %

Shares outstanding

8.529 B

Synektik SA provides medical and information technology solutions. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 145 full-time employees. The company went IPO on 2011-08-09. The company produces PACS software which allows running a diagnostic imaging laboratory. The company runs a research laboratory which performs acceptance and specialist tests of X-ray equipment. The firm sells medical equipment and operates a services center for imaging equipment. Synektik SA is a partner of Siemens. On November 28, 2013, the Company raised its stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o to 100%.

View Section: Eyestock Rating